Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:47 pm Purchase | 2021-02-04 | 13G | Larimar Therapeutics, Inc. LRMR | Logos Global Master Fund LP | 300,000 2.000% | 300,000 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | RA Capital Management, L.P. | 1,515,151 9.900% | 1,515,151 (New Position) | Filing History |
| 2021-02-16 3:11 pm Purchase | 2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | 683 Capital Management, LLC | 220,136 1.400% | 220,136 (New Position) | Filing History |
| 2021-02-16 1:03 pm Purchase | 2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | Sio Capital Management LLC | 188,661 1.230% | 188,661 (New Position) | Filing History |
| 2021-02-16 08:57 am Unchanged | 2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | SPHERA FUNDS MANAGEMENT LTD. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-16 06:11 am Purchase | 2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | ACUTA CAPITAL PARTNERS LLC | 863,100 5.600% | 863,100 (New Position) | Filing History |
| 2021-02-12 4:57 pm Purchase | 2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | ORBIMED ADVISORS LLC | 732,323 4.770% | 732,323 (New Position) | Filing History |
| 2021-02-10 7:02 pm Purchase | 2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | Renaissance Technologies LLC | 221,374 1.440% | 221,374 (New Position) | Filing History |
| 2021-02-02 1:04 pm Purchase | 2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | Atlas Venture Fund VII L P | 292,182 1.900% | 292,182 (New Position) | Filing History |